Open AccessLamivudine therapy for children with chronic hepatitis B
Author(s) -
Anna Liberek,
Anna Szaflarska-Popławska,
Maria Korzon,
Grażyna Łuczak,
Magdalena Góra-Gębka,
Ewa Łoś-Rycharska,
Wanda Bako,
Mieczysława Czerwionka-Szaflarska
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i15.2412
Subject(s) - lamivudine , medicine , hbeag , gastroenterology , discontinuation , seroconversion , hepatitis b , hepatitis b virus , alpha interferon , combination therapy , hbsag , immunology , antibody , interferon , virus
To assess the effectiveness and side-effects of lamivudine therapy for children with chronic hepatitis B (CHB) who fail to respond to or have contraindications to interferon-alpha (IFN-alpha) therapy.